Business Context and Reporting Period
This Form 8-K Current Report was filed by WhiteHorse Finance, Inc. on December 21, 2020. The filing details a material definitive agreement entered into by WhiteHorse Finance Credit I, LLC, a wholly owned subsidiary of the Company, regarding its credit facility.
Key Financial Metrics and Debt Structure
The filing focuses on the amendment of the Fourth Amended and Restated Loan Agreement. Key terms of the amended facility include:
- Minimum Funding Amount: Increased from $175 million to $200 million.
- Facility Size: Increased from $250 million to $285 million.
- Accordion Feature: Retained, allowing for expansion of the borrowing limit up to $350 million.
- Interest Rate Benchmark: Provisions implemented to transition away from the London Interbank Offered Rate (LIBOR).
The filing text does not provide specific values for revenue, profit, cash flow, margins, or overall liquidity positions for the reporting period.
Material Changes Versus Prior Period
The primary material change is the expansion of the Company's credit facility capacity and the adjustment of minimum funding requirements. Additionally, the agreement was updated to address market-wide changes regarding the phase-out of LIBOR.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements, noting that actual results may differ materially due to various risks and uncertainties. The Company explicitly states it undertakes no duty to update any forward-looking statements made in the report. No specific financial guidance or management commentary on future performance metrics is provided in this document.
Important Facts for Investor Verification
- Verify the full text of the First Amendment to the Fourth Amended and Restated Loan Agreement filed as Exhibit 10.1.
- Confirm the impact of the increased minimum funding requirement ($200 million) on the Company's capital deployment strategy.
- Monitor the implementation timeline and mechanics of the LIBOR transition provisions within the loan agreement.
- Review subsequent filings for details on the utilization of the expanded $285 million facility and any exercise of the accordion feature up to $350 million.